Inventor · disambiguated record
Sabine Hoves
Also filed as: HOVES SABINE
11 granted patents·7 pending applications·65 citations·filing 2014–2024
88Inventor score
Files withHOFFMANN LA ROCHE18
Top patents by PatentIndex Score
18 records- 0192US9192667B2Method of treating cancer by administering CSF-1R antibodies and a TLR9 agonistHOFFMANN LA ROCHE·Filed 2014·Granted Nov 24, 2015·22 cites·13 claims
- 0291US9597333B2Benzazepine dicarboxamide compoundsHOFFMANN LA ROCHE·Filed 2016·Granted Mar 21, 2017·10 cites·17 claims
- 0389US9447097B24-amino-imidazoquinoline compoundsHOFFMANN LA ROCHE·Filed 2016·Granted Sep 20, 2016·8 cites·14 claims
- 0489US9334268B24-amino-imidazoquinoline compoundsHOFFMANN LA ROCHE·Filed 2015·Granted May 10, 2016·9 cites·23 claims
- 0587US9822065B1Benzazepine dicarboxamide compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Nov 21, 2017·5 cites·5 claims
- 0687US9475775B2Benzazepine dicarboxamide compoundsHOFFMANN LA ROCHE·Filed 2016·Granted Oct 25, 2016·6 cites·19 claims
- 0784US9890124B2Benzazepine sulfonamide compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Feb 13, 2018·5 cites·20 claims
- 0879US2025051456A1Anti-hla-g antibodies and methods of use thereofHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0970US2015073129A1Combination therapy of antibodies against human CSF-1R and antibodies agains human PD-L1HOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1068US11512133B2Methods for treating colon cancer or inhibiting cell proliferation by administering a combination of antibodies against human CSF-1R and antibodies against human PD-L1HOFFMANN LA ROCHE·Filed 2020·Granted Nov 29, 2022·0 cites·14 claims
- 1164US12157770B2Anti-HLA-G antibodies and methods of use thereofHOFFMANN LA ROCHE·Filed 2020·Granted Dec 3, 2024·0 cites·11 claims
- 1262US2018346581A1Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1HOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 1358US2017051065A1Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1HOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1449US2016220669A1Combination therapy of antibodies against human csf-1r and tlr9 agonistHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1548US2018273628A1Generation of human macrophages in immunodeficient non-human hostsHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 1644US10428027B2Sulfinylphenyl or sulfonimidoylphenyl benzazepinesHOFFMANN LA ROCHE·Filed 2018·Granted Oct 1, 2019·0 cites·19 claims
- 1739US2020268762A17-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of liver cancerHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1837US11542335B2Method of treating cancer in a patient by administering an antibody which binds colony stimulating factor-1 receptor (CSF-1R)HOFFMANN LA ROCHE·Filed 2019·Granted Jan 3, 2023·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Sabine Hoves files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →